The hype surrounding hydroxychloroquine (HCQ) as a potential treatment for COVID-19 has led to problems for patients who use the drug to treat conditions like lupus, leading to shortages in pharmacies and worries about potentially dangerous side-effects, according to rheumatologists. Read more in The Lancet Rheumatology.